Cargando…
Poloxamer-188 Adjuvant Efficiently Maintains Adaptive Immunity of SARS-CoV-2 RBD Subunit Vaccination through Repressing p38MAPK Signaling
Poloxamer-188 (P188) is a nonionic triblock linear copolymer that can be used as a pharmaceutical excipient because of its amphiphilic nature. This study investigated whether P188 can act as an adjuvant to improve the immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rec...
Autores principales: | Chen, Chao-Hung, Lin, Yu-Jen, Cheng, Li-Ting, Lin, Chien-Hung, Ke, Guan-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145454/ https://www.ncbi.nlm.nih.gov/pubmed/35632471 http://dx.doi.org/10.3390/vaccines10050715 |
Ejemplares similares
-
Mechanical, Rheological and Release Behaviors of a Poloxamer 407/Poloxamer 188/Carbopol 940 Thermosensitive Composite Hydrogel
por: Chen, Jianping, et al.
Publicado: (2013) -
Electrodelivery of Drugs into Cancer Cells in the Presence of Poloxamer 188
por: Tsoneva, Iana, et al.
Publicado: (2010) -
Thermosensitive Polymer Blend Composed of Poloxamer 407, Poloxamer 188 and Polycarbophil for the Use as Mucoadhesive In Situ Gel
por: Hirun, Namon, et al.
Publicado: (2022) -
The Effect of Glucose and Poloxamer 188 on Red-Blood-Cell Aggregation
por: Szołna-Chodór, Alicja, et al.
Publicado: (2021) -
Differential Effects of Commercial-Grade and Purified Poloxamer 188 on Renal Function
por: Emanuele, Martin, et al.
Publicado: (2014)